Value-based contracts
Payer-provider agreements in which a portion of reimbursement is contingent on meeting quality, cost, or outcomes targets rather than purely on the volume of services delivered. Value-based contracts range from simple pay-for-performance arrangements (bonus payments for meeting quality benchmarks) to complex risk-sharing models (where the provider shares in savings or losses against a total cost of care target).
Why this matters for your clinic
Value-based contracts introduce performance variables into your revenue that do not exist under traditional fee-for-service agreements. Bonuses for quality performance can add meaningful upside. Downside risk provisions can subtract from base revenue if cost targets are missed. Understanding exactly which metrics are measured, how they are scored, and what the financial stakes are at each performance level is essential before signing.
The data requirements under value-based contracts are significantly higher than under FFS. You need to track quality measures, report on attributed patient outcomes, monitor referral patterns, and in some cases submit supplemental clinical data to the payer. Practices that lack reporting infrastructure often underperform on value-based metrics relative to their actual clinical quality simply because they cannot produce the data the contract requires.
Contract term and settlement timing are the two most overlooked provisions in value-based agreements. Performance is typically measured over a year and settled 12-18 months later. If your contract includes downside risk, you need to hold reserves against a potential settlement payment. If it includes shared savings, you need to forecast the upside conservatively and not budget for it before it arrives.
What good looks like
HCPLAN surveys commercial payer value-based contract penetration annually. The 2024 HCPLAN APM Measurement report showed roughly 36% of commercial health plan payments flowing through some form of alternative payment model. CMS CMMI models provide public reference data on bonus and penalty ranges in government-administered value-based contracts.
Example
A multi-specialty group signs a value-based contract with a commercial payer covering 8,000 attributed members. The contract pays base FFS rates plus a potential 5% bonus on total FFS revenue if the group achieves four quality benchmarks and keeps total cost of care within 3% of a prior-year baseline. Total FFS revenue at risk: $3.2M. Bonus potential: $160,000 per year. The group needs to track all four quality measures monthly and model cost-of-care trends quarterly to know where they stand before year-end settlement.
From Sorso
We treat every value-based contract as a separate financial entity when we model client revenue. The bonus upside has to be separated from base FFS revenue in the forecast, and any downside risk provision has to be reserved against. Mixing them into a blended revenue number hides the risk.
Founder of Sorso. 19 years in corporate finance. Managed a $450M loan portfolio before building a fractional CFO firm exclusively for healthcare clinics.
Want to see how your practice measures up?
Take the 4-minute financial assessment. It is free, and it will show you where your practice is leaking money.